Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-François Bergmann

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Therapie|July 10, 2016
Good Medical Practice for Drugs. Definition, Guidelines, References, Field of Action and ApplicationsJean-François Bergmann,
Fundamental & Clinical Pharmacology|June 14, 2003
Self-medication: from European regulatory directives to therapeutic strategyJean-François Bergmann
Seminars in Thrombosis and Hemostasis|September 17, 2002
Thromboprophylaxis in medical patients: focus on FranceJean-François Bergmann, Stéphane Mouly
Drug Safety|April 6, 2004
Does paracetamol potentiate the effects of oral anticoagulants?: a literature reviewIsabelle Mahé, Charles Caulin, Jean-François Bergmann
Therapie|February 5, 2017
How to measure the net benefit of treatment?François Gueyffier, Pascal Piedbois, Jean-François Bergmann, et al.
Current Treatment Options in Cardiovascular Medicine|July 12, 2005
Which treatment for patent foramen ovale in cryptogenic stroke?Isabelle Mahé, Charles Caulin, Jean-François Bergmann
Intensive Care Medicine|January 10, 2009
Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4Stéphane Mouly, Christophe Meune, Jean-François Bergmann
Therapie|February 13, 2019
Early access to health products in France: Major advances of the French "Conseil stratégique des industries de santé" (CSIS) to be implemented (modalities, regulations, funding)Nicolas Albin, Frédéric Chassagnol, Jean-François Bergmann, et al.
La Revue Du Praticien|March 4, 2009
[Prevalence and prevention of venous thromboembolic events in general practice. Multicenter, prospective cohort study]Denis Pouchain, Jean-François Bergmann, Jean-Luc Bosson
Therapie|November 28, 2006
Protocolisation, use and development of anti-cancer drugs in the context of T2A (case-mix based payment system) set-upAnne Mathieu-Boué, Pierre Demolis, Jean-François Bergmann
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Therapie|July 10, 2016
Good Medical Practice for Drugs. Definition, Guidelines, References, Field of Action and ApplicationsJean-François Bergmann,
Fundamental & Clinical Pharmacology|June 14, 2003
Self-medication: from European regulatory directives to therapeutic strategyJean-François Bergmann
Seminars in Thrombosis and Hemostasis|September 17, 2002
Thromboprophylaxis in medical patients: focus on FranceJean-François Bergmann, Stéphane Mouly
Drug Safety|April 6, 2004
Does paracetamol potentiate the effects of oral anticoagulants?: a literature reviewIsabelle Mahé, Charles Caulin, Jean-François Bergmann
Therapie|February 5, 2017
How to measure the net benefit of treatment?François Gueyffier, Pascal Piedbois, Jean-François Bergmann, et al.
Current Treatment Options in Cardiovascular Medicine|July 12, 2005
Which treatment for patent foramen ovale in cryptogenic stroke?Isabelle Mahé, Charles Caulin, Jean-François Bergmann
Intensive Care Medicine|January 10, 2009
Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4Stéphane Mouly, Christophe Meune, Jean-François Bergmann
Therapie|February 13, 2019
Early access to health products in France: Major advances of the French "Conseil stratégique des industries de santé" (CSIS) to be implemented (modalities, regulations, funding)Nicolas Albin, Frédéric Chassagnol, Jean-François Bergmann, et al.
La Revue Du Praticien|March 4, 2009
[Prevalence and prevention of venous thromboembolic events in general practice. Multicenter, prospective cohort study]Denis Pouchain, Jean-François Bergmann, Jean-Luc Bosson
Therapie|November 28, 2006
Protocolisation, use and development of anti-cancer drugs in the context of T2A (case-mix based payment system) set-upAnne Mathieu-Boué, Pierre Demolis, Jean-François Bergmann
Pageof 11